Swiss National Bank trimmed its position in shares of STERIS plc (NYSE:STE - Free Report) by 5.0% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 278,560 shares of the medical equipment provider's stock after selling 14,800 shares during the period. Swiss National Bank owned approximately 0.28% of STERIS worth $57,261,000 at the end of the most recent quarter.
A number of other large investors have also recently bought and sold shares of STE. Human Investing LLC acquired a new stake in STERIS during the fourth quarter worth about $31,000. Anfield Capital Management LLC boosted its stake in shares of STERIS by 100.0% in the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock valued at $37,000 after purchasing an additional 91 shares in the last quarter. Central Pacific Bank Trust Division boosted its stake in shares of STERIS by 65.5% in the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock valued at $39,000 after purchasing an additional 76 shares in the last quarter. Manchester Capital Management LLC boosted its stake in shares of STERIS by 182.7% in the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock valued at $44,000 after purchasing an additional 137 shares in the last quarter. Finally, Quarry LP acquired a new stake in shares of STERIS in the 3rd quarter valued at approximately $67,000. 94.69% of the stock is currently owned by institutional investors and hedge funds.
STERIS Trading Down 1.3 %
NYSE:STE traded down $2.89 during mid-day trading on Wednesday, hitting $225.44. 450,565 shares of the company's stock were exchanged, compared to its average volume of 521,652. The company has a 50 day simple moving average of $220.09 and a 200-day simple moving average of $222.22. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. STERIS plc has a fifty-two week low of $197.82 and a fifty-two week high of $248.24. The firm has a market capitalization of $22.15 billion, a P/E ratio of 47.86 and a beta of 0.92.
STERIS (NYSE:STE - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. As a group, research analysts expect that STERIS plc will post 9.08 earnings per share for the current year.
STERIS Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, March 21st. Shareholders of record on Thursday, February 20th will be issued a dividend of $0.57 per share. The ex-dividend date is Thursday, February 20th. This represents a $2.28 annualized dividend and a yield of 1.01%. STERIS's payout ratio is 48.41%.
Analysts Set New Price Targets
STE has been the topic of a number of research analyst reports. Piper Sandler raised their price target on shares of STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research note on Monday, February 3rd. JMP Securities restated a "market outperform" rating and issued a $265.00 price target on shares of STERIS in a research note on Thursday, February 6th. Finally, Stephens reiterated an "overweight" rating and set a $240.00 target price on shares of STERIS in a research report on Thursday, February 6th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $258.75.
View Our Latest Stock Analysis on STERIS
About STERIS
(
Free Report)
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
Recommended Stories
Before you consider STERIS, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and STERIS wasn't on the list.
While STERIS currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
